Interview coverage of the study group.

<p>Interview coverage of the study group.</p

Socio-demographic profile of HIV infected TB patients interviewed N = 176.

*<p>includes separated (10), widowed (27).</p>**<p>For those employed (105).</p

Treatment outcomes of HIV infected TB patients according to Disease classification N = 281.

<p>( ) Percentage.</p

Disease Classification and CD4 counts in HIV infected TB patients N = 281.

<p>IQR – Inter Quartile Range.</p>*<p>Six smear negative patients had milliary tuberculosis and their median CD4 count was 120. (95–124).</p>**<p>One smear status not available.</p

Univariate analysis of the treatment related factors associated with survival status (N = 281).

<p>OR - Odds Ratio, CI- Confidence interval.</p>*<p>Smear status is given only for those with pulmonary TB. Smear status not available for one patient,</p>**<p>Excludes 16 patients for whom treatment cards were not available (6 in dead and 10 in survived).</p>#<p>For 47 and 26 CD4 counts were not available in dead and survived patients respectively.</p

Association of treatment related risk factors with TB treatment outcome and with survival status.

<p>aOR- Adjusted Odds Ratio, CI – Confidence Interval.</p

Survey enrollment and inclusion, with reasons for non-eligibility and non-enrollment into survey.

<p>Survey enrollment and inclusion, with reasons for non-eligibility and non-enrollment into survey.</p

Trends in HIV seroprevalence among tuberculosis patients in 4 districts, 2005–6 survey and 2006–7 surveys.

<p>Trends in HIV seroprevalence among tuberculosis patients in 4 districts, 2005–6 survey and 2006–7 surveys.</p

Districts selected for the survey.

<p>District selection stratified by mean HIV seroprevalence in antenatal clinic (ANC) surveillance sites, 2003–2005. Districts shaded blue had mean 2003–2005 ANC HIV seroprevalence 0–0.5%, yellow districts had ANC HIV seroprevalence 0.51–1.0%, and red districts had ANC HIV seroprevalence >1.0%. The districts of Davangere, Guntur, Nasik, and Tiruvanamalai were selected in the previous years' survey, and were purposively selected again for trend analysis.</p

HIV seroprevalence among tuberculosis patients in 15 districts in India, 2006–2007.

a<p>Districts stratified by mean HIV seroprevalence in antenatal clinic (ANC) surveillance sites, 2003–2005. Low <0.5%, Medium = 0.51–1.0%, High >1.0%.</p